Search Results

This report is a briefing for health practitioners, TB program staff, policymakers, media professionals, and people affected by TB. It argues for the need for more media coverage of TB.

This report outlines a strategy for management of human resources for TB control.

This report includes a description and evaluation of a national media campaign that Development Media International (DMI) conducted in April 2006 to promote treatment of tuberculosis (TB) in Brazil, in partnership with the Ministry of Health of Brazil, the World Health Organization (WHO), and the...

This report is a briefing for health practitioners, TB program staff, policymakers, media professionals, and people affected by TB. It argues for the need for more media coverage of TB.

This manual provides information about TB program reviews and planning and technical support. It provides a view of international partnership towards the goal of eliminating TB.

This video summarizes the key elements of the multi-faceted, private-public partnership that has been assembled by Lilly to meet the challenge of MDR-TB.
Several world-recognized experts from academia, international agencies, and from within the company talk about the challenges that developing...

This guideline promotes collaboration between TB and HIV/AIDS programs to reduce the burden for people affected by both diseases.

This booklet explains the action and resources needed over the next five years for six working groups to expand, adapt, and improve DOTS, enabling the working groups to meet the 2005 global targets of setting the world on the road to the elimination of TB.

This booklet explains the action and resources needed over the next five years for six working groups to expand, adapt, and improve DOTS, enabling the working groups to meet the 2005 global targets of setting the world on the road to the elimination of TB.

This booklet explains the relationship between MDR-TB, DOTS, and DOTS-Plus and how projects can become a DOTS-Plus pilot project that can benefit from concessionary prices negotiated for second-line anti-TB drugs by the Working Group.